Chadbourne & Parke represented the shareholders of ООО AnviLab in the sale of 100% of the company to Protek Group for $60 million.
AnviLab owns the rights for such pharmaceutical brands as Antigrippin-Maximum, Gepaguard, Influnet and is the legal owner of the ANVI Laboratory brand. The assets acquired under the transaction will pass into management of Protek Group whose key company in the production segment is CJSC Farmfirma Sotex.
Tags: Moscow







